Policy Briefings

Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know

MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales

China Aims for 25% of Global First-in-Class Drugs by 2030

AstraZeneca Signs Trump’s Second MFN Drug Pricing Deal

Trump Exempts Generic Drugs from Pharmaceutical Tariffs, Boosting Indian Pharma Stocks

UK Considers Raising NHS Drug Prices to Avoid US Tariffs

Trump Delays 100% Pharma Tariffs to Negotiate Pricing Deals

TrumpRx: Pfizer Signs First Deal for US Drug Platform

Trump’s 100% Pharma Tariffs to United States from October 1: How the industry is responding

Trump Administration Draws Autism-Acetaminophen Link Despite Scientific Skepticism

RFK Jr’s Vaccine Panel Expected to Delay Newborn Hepatitis B Shots Until Age 4

US-EU Trade Deal Caps Pharmaceutical Tariffs at 15%, Averting Higher Levies

TAPI Appoints Serge Rogasik as Chief Executive Officer

ALK Expands Catalent Partnership to Secure Long-Term Allergy Tablet Supply

OnDosis and Adare Pharma Solutions Launch U.S. ADHD Drug-Device Collaboration

Ensera Launches Alliance Network for Drug-Device Combination Products

Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center

NorthStar Medical Technologies Secures Up to $185M Growth Capital Facility

Piramal Pharma Solutions Receives $1.75M Ontario Investment for Aurora Site

Minaris Adds Viral Vectors Business Unit to Expand CGT Model

Genezen Partners on AAV9 Gene Therapy for Ultra-Rare ARCA2 Disorder

ESTEVE CDMO Expands Morton Grove Facility With $33M Total Investment

Forge Biologics Partners With TECPR2 Research Foundation on AAV Gene Therapy

Axplora Completes First R&D Batches of Exatecan for ADC Developers

Serán Bioscience Announces Growth Investment to Expand Commercial Manufacturing

Quotient Sciences and Acesion Pharma Launch AI Formulation Collaboration

CARBOGEN AMCIS Completes First FDA Pre-Approval Inspection at Vionnaz

Biodextris Appoints Clement Fourny as Chief Executive Officer

Lifecore Biomedical Agrees to $663.7M Acquisition by Webster Equity Partners

4basebio Partners With TriLink on Cell Therapy Manufacturing Program

European CDMO Landscape 2025: Download the latest edition